Jointown Pharmaceutical Group Co., Ltd. Class ASSE: 600998

Announcement on Outline of the Q3 2025 Performance Briefing

· Issued by Jointown Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Outline of the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment